Molecular Therapy - Methods & Clinical Development

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Cardiac-Specific Overexpression of HIF-1α Prevents Deterioration of Glycolytic Pathway and Cardiac Remodeling in Streptozotocin-Induced Diabetic Mice 
Volume 16, Issue 3, Pages (March 2008)
Development of a Rab9 Transgenic Mouse and Its Ability to Increase the Lifespan of a Murine Model of Niemann-Pick Type C Disease  Tatiana Kaptzan, Sally.
Lack of Specificity of Commercial Antibodies Leads to Misidentification of Angiotensin Type 1 Receptor ProteinNovelty and Significance by Marcela Herrera,
Molecular Therapy - Oncolytics
Volume 5, Issue 1, Pages (July 2015)
Volume 69, Issue 6, Pages (March 2006)
Kuo-Jung Li, Ai-Li Shiau, Yuan-Yow Chiou, Yi-Te Yo, Chao-Liang Wu 
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Volume 64, Issue 6, Pages (June 2016)
Volume 137, Issue 2, Pages e2 (August 2009)
Molecular Therapy - Methods & Clinical Development
Jack C. Reidling, Nils Lambrecht, Mohammad Kassir, Hamid M. Said 
Volume 10, Issue 4, Pages (October 2004)
Comparative gene expression profiling of adult mouse ovary-derived oogonial stem cells supports a distinct cellular identity  Anthony N. Imudia, M.D.,
Peritubular cells may modulate Leydig cell–mediated testosterone production through a nonclassic pathway  Jibanananda Mishra, Ph.D., Mukesh Gautam, M.Sc.,
Molecular Therapy - Nucleic Acids
Roger B. Deal, Steven Henikoff  Developmental Cell 
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Qian Yang, Atsushi Yamada, Shioko Kimura, Jeffrey M. Peters, Frank J
Rose-Anne Romano, Barbara Birkaya, Satrajit Sinha 
Volume 4, Issue 6, Pages (December 2001)
Volume 64, Issue 6, Pages (June 2016)
Volume 20, Issue 5, Pages (May 2012)
Volume 25, Issue 6, Pages (June 2017)
The Mouse Spo11 Gene Is Required for Meiotic Chromosome Synapsis
Volume 154, Issue 6, Pages (September 2013)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Methods & Clinical Development
Analysis of Mouse Keratin 6a Regulatory Sequences in Transgenic Mice Reveals Constitutive, Tissue-Specific Expression by a Keratin 6a Minigene  Donna.
Hosein Kouros-Mehr, Euan M. Slorach, Mark D. Sternlicht, Zena Werb 
Volume 75, Issue 4, Pages (February 2009)
Wenqian Hu, Bingbing Yuan, Harvey F. Lodish  Developmental Cell 
Volume 73, Issue 4, Pages (February 2008)
High-accuracy biodistribution analysis of adeno-associated virus variants by double barcode sequencing  Damien Marsic, Héctor R Méndez-Gómez, Sergei Zolotukhin 
Andriana G Kotini, Michel Sadelain, Eirini P Papapetrou 
Volume 26, Issue 1, Pages (January 2018)
Molecular Therapy - Nucleic Acids
Volume 56, Issue 4, Pages (October 1999)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases  Li Xu, Piming Zhao, Andrew Mariano, Renzhi.
Volume 23, Issue 10, Pages (October 2015)
Richard A Voit, Moira A McMahon, Sara L Sawyer, Matthew H Porteus 
Trangenic Misexpression of the Differentiation-Specific Desmocollin Isoform 1 in Basal Keratinocytes  Frank Henkler, Molly Strom, Kathleen Mathers, Hayley.
J.P O'Rourke, H Hiraragi, K Urban, M Patel, J.C Olsen, B.A Bunnell 
Volume 10, Issue 5, Pages (May 2018)
A Role for Estrogen Receptor-α and Estrogen Receptor-β in Collagen Biosynthesis in Mouse Skin  Margaret Markiewicz, Sergey Znoyko, Lukasz Stawski, Angela.
Volume 17, Issue 2, Pages (February 2009)
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Increased Expression of Laminin Subunit Alpha 1 Chain by dCas9-VP160
Volume 25, Issue 2, Pages (February 2017)
Drosophila Maelstrom Ensures Proper Germline Stem Cell Lineage Differentiation by Repressing microRNA-7  Jun Wei Pek, Ai Khim Lim, Toshie Kai  Developmental.
Overexpression of Fetuin-A Counteracts Ectopic Mineralization in a Mouse Model of Pseudoxanthoma Elasticum (Abcc6−/−)  Qiujie Jiang, Florian Dibra, Michael.
Volume 23, Issue 12, Pages (December 2015)
Bhola Shankar Pradhan, Subeer S. Majumdar 
Kasey L Jackson, Robert D Dayton, Ronald L Klein 
Effect of Tenascin-C Deficiency on Chemically Induced Dermatitis in the Mouse  Yoh-ichi Koyama, Masashi Kusubata, Atsushi Yoshiki, Noriko Hiraiwa, Tomoo.
Molecular Therapy - Nucleic Acids
Volume 18, Issue 7, Pages (July 2010)
Jiamiao Lu, Feijie Zhang, Mark A Kay  Molecular Therapy 
Quan Jin, Chunping Qiao, Jianbin Li, Juan Li, Xiao Xiao 
Volume 21, Issue 2, Pages (February 2013)
Fetal Brain-directed AAV Gene Therapy Results in Rapid, Robust, and Persistent Transduction of Mouse Choroid Plexus Epithelia  Marie Reine Haddad, Anthony.
Volume 24, Issue 10, Pages (October 2016)
Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter  Lawrence E Ostrowski, James R Hutchins,
Volume 13, Issue 1, Pages (January 2006)
Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan.
Molecular Therapy - Methods & Clinical Development
Presentation transcript:

Molecular Therapy - Methods & Clinical Development Robust generation of transgenic mice by simple hypotonic solution mediated delivery of transgene in testicular germ cells  Abul Usmani, Nirmalya Ganguli, Subodh K Jain, Nilanjana Ganguli, Rajesh Kumar Sarkar, Mayank Choubey, Mansi Shukla, Hironmoy Sarkar, Subeer S Majumdar  Molecular Therapy - Methods & Clinical Development  Volume 3, (January 2016) DOI: 10.1038/mtm.2016.76 Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Transfection of transgene in the testis by hypotonic solution. (a) Enhanced green fluorescence protein (EGFP) expression in transfected testis transfected with pCX-Egfp suspended in 150 mmol/l Tris-HCl. i–v: Tissue Section of nontransfected testis. vi–x: Tissue section of transfected testis. EGFP expression was observed mostly in germ cells (yellow arrow head) of transfected testis. Lack of EGFP expression in nontransfected tubules and germ cells of treated testis (red arrow head). Note: Nonspecific signal (white head) in the interstitial space of the testis was observed in both treated and wildtype animal's tissue section. Scale bar: 50 μm. (b) Seminiferous tubule showing EGFP in germ cells at higher magnification of the partial section of figure - a x. Scale bar: 50 μm. The thick white line is added for better differentiation of one tubuler region from another. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.76) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Generation of transgenic animal with Bucsn2-IRES2-Egfp construct. (a) Polymerase chain reaction (PCR) genotyping of the offspring from generation one (G1) and generation two (G2) to detect transgenic animal. In the G1 pups, except the TBa2, Tba7, TBc4-6 all are found to be PCR positive. Wt represents the genomic DNA (gDNA) from wild type animal as PCR negative control concludes that primer pair did not amplify the endogenous gene. +ve represents the plasmid construct DNA as a PCR positive control. (b) Mammary gland of lactating (day 7 of lactation) transgenic female mice (TBc 7) carrying Bucsn2-IRES2-Egfp transgene, as observed under stereozoom fluorescence microscope. Image (i) show the wild type mammary gland. Image (iii) show EGFP fluorescence in gland of transgenic mice. Image (ii) and (iv): corresponding phase contrast image of wild type and transgenic mice, respectively. (c) Immunohistochemistry to detect GFP expression in the mammary alveoli of female mice carrying Bucsn2-IRES2-Egfp transgene. GFP expression was observed in transgenic mice mammary gland (i) whereas there was no GFP expression in mammary gland of wild type mice (iii). Yellow arrow marks the presence of GFP expression in the milk space of transgenic mice mammary gland. Red arrow marks the absence of GFP expression in the milk space of wildtype mice mammary gland. Yellow line mark the boundary of mammary alveoli. Image ii and iv are the corresponding phase contrast image of transgenic (i) and wild type (iii). Scale bar 50 μm. (d) Expression of EGFP by western blot in protein from (i) mammary glands of three different transgenic females and two different wild type mice and (ii) various tissues (liver, spleen, brain, heart, mammary gland, and kidney) of lactating (day 7 of lactation) transgenic female mice (TBc 7) carrying Bucsn2-IRES2-Egfp transgene EGFP expression (~28 kDa) was observed in transgenic mice whereas there is no EGFP signal in wild type mice. EGFP expression (~28 kDa) was present only in mammary gland sample and not in other tissue type of the animal. β-actin was used as loading control. EGFP, enhanced green fluorescence protein. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.76) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Validation of Amh-IRES2-Egfp transgenic mice. (a) PCR genotyping of the offspring using genomic DNA (gDNA) obtained from G0 founder MG1 transfected with Amh-IRES2-Egfp. MG1 was mated with wild type female mice. MG denotes the G0 founder animal of Amh-IRES2-Egfp. MT denotes transgenic animal of Amh-IRES2-Egfp line. Wt denotes wild type mice. NT denotes no template. +ve denotes plasmid DNA. EGFP, enhanced green fluorescence protein; G1, Generation 1; MT, Pups from Amh-IRES2-Egfp Transgenic mice; PCR, polymerase chain reaction.(b) Position of BamH1 restriction-enzyme and probe for southern blot on transgene construct. (c) Southern blot analysis of genomic DNA (gDNA) isolated from tail biopsy of Amh-IRES2-Egfp transgenic mice, showing integration of transgene in multiple sites. wt1 and wt2 denote gDNA isolated from two different wild type animals. MT21, MT22, MT23, and MT25 denotes gDNA isolated from different pups born from transgenic animals MG1, where 21, 22, and 25 were PCR positive and 23 was PCR negative pups. L denotes 1 kb DNA ladder (NEB, USA). The molecular weights of the bands mentioned in the ladder are in Kb. (d) EGFP expression in Sertoli cells of 5 days old Amh-IRES2-Egfp transgenic mice (i, ii) compared with the wild type control. Yellow arrow head shows the EGFP fluorescence in the Sertoli cells inside seminiferous tubules. White arrow marks the nonspecific staining in Leydig Cells. Scale bar: 10 μm. (e) Detection of EGFP protein (~28 kDa band) by Western blot analysis from testis of 5 days old three transgenic mice compared with age matched wild-type mice testis. β-actin was used as loading control. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.76) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Evaluation of Fetuin A knockdown in mice. (a) Slot blot analysis of the progeny from generation one (G1) obtained from the G0 founder males transfected with Fetuin A-shRNA; 1FT, 2FT, and 3FT are three different G0 founder males. FT denotes Fetuin- A shRNA expressing transgenic mice. Wt denotes wild type mice. (b) Relative fold changes in Fetuin A mRNA expression of transgenic animals relative to wild type animals. wt, wild type mice, FT10–F15 represents five different transgenic animals. Each bar generated from n = 3 qRTPCR of same sample, represented as mean ± SEM. ***P < 0.001. (c) Von kossa staining in Fetuin A knockdown mice for detection of increased calcium deposition in heart (black spots). (i) Wild type, (ii) Transgenic, and (iii) Enlarged view of Transgenic Heart. SEM, standard error of the mean; qRTPCR, quantitative real time polymerase chain reaction. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.76) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions